| ABRYX | CRAZX | ABRYX / CRAZX | |
| Total Expense Ratio | 1.16 | 0.81 | 143% |
| Annual Report Gross Expense Ratio | 1.21 | 0.81 | 149% |
| Fund Existence | 17 years | 14 years | - |
| Gain YTD | 22.830 | 10.482 | 218% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 2000 | 50% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 953M | 2.63B | 36% |
| Annual Yield % from dividends | 2.90 | 2.62 | 111% |
| Returns for 1 year | 28.00 | 14.99 | 187% |
| Returns for 3 years | 41.43 | 44.15 | 94% |
| Returns for 5 years | 11.51 | 8.60 | 134% |
| Returns for 10 years | 35.20 | 40.36 | 87% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FDM | 93.70 | 0.62 | +0.67% |
| First Trust Dow Jones Sel MicroCap ETF | |||
| XLII | 25.09 | 0.11 | +0.44% |
| State Street® IndstrlSelSectSPDR®PrmETF | |||
| CCOM | 23.87 | -0.05 | -0.21% |
| Simplify Chinese Cmdts Stgy No K-1 ETF | |||
| DVAL | 16.66 | -0.06 | -0.38% |
| BrandywineGLOBAL Dyn US Lrg Cap Val ETF | |||
| FTXH | 41.77 | -0.44 | -1.05% |
| First Trust Nasdaq Pharmaceuticals ETF | |||